J P Morgan Chase & Co reaffirmed their buy rating on shares of Roche Holding Ltd. (VTX:ROG) in a research report released on Monday.
A number of other brokerages also recently commented on ROG. Barclays PLC set a CHF 305 target price on Roche Holding and gave the company a buy rating in a research note on Tuesday, June 13th. Kepler Capital Markets set a CHF 231 target price on Roche Holding and gave the company a neutral rating in a research note on Tuesday, June 6th. Deutsche Bank AG set a CHF 273 target price on Roche Holding and gave the company a buy rating in a research note on Tuesday, June 6th. HSBC Holdings plc set a CHF 215 target price on Roche Holding and gave the company a sell rating in a research note on Tuesday, June 6th. Finally, Goldman Sachs Group, Inc. (The) set a CHF 335 target price on Roche Holding and gave the company a buy rating in a research note on Tuesday, June 6th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and eight have given a buy rating to the company’s stock. The company currently has a consensus rating of Buy and a consensus price target of CHF 273.38.
Roche Holding (VTX ROG) traded down 1.14% during mid-day trading on Monday, reaching CHK 243.20. The company’s stock had a trading volume of 1,262,165 shares. The firm has a 50-day moving average of CHK 259.00 and a 200-day moving average of CHK 249.75. The stock has a market capitalization of CHK 207.20 billion and a price-to-earnings ratio of 20.87. Roche Holding has a 52 week low of CHK 218.30 and a 52 week high of CHK 273.00.
Roche Holding Company Profile
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
